← Eichor
Study identifier: NCT06153420 Synced from ClinicalTrials.gov · July 28, 2026
● Terminated

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Condition: Irritable Bowel Syndrome With Diarrhea  ·  Sponsor: CinPhloro Pharma, LLC

PhasePhase 2
Planned participants421
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with predominant diarrhea (IBS-D) in adult patients. The main questions it aims to answer are: * To evaluate the efficacy of CIN-103 on symptoms of IBS-D when given to patients with IBS-D compared to a placebo. * To evaluate the safety and tolerability of CIN-103 when given to patients with IBS-D compared to a placebo Participants will attend the following visits: * Screening Period (1 Visit) * Baseline Period (1 Visit) * Will complete daily diary and other Patient Reported Outcomes (PROs) as described in the protocol to assess eligibility for continued participation. * 12-Week Treatment Period (5 Visits) * Study drug taken twice daily by mouth. * Will complete daily diaries and other PROs as described in the protocol. * Follow- Up Period (1 Visit) Researchers will compare CIN-103 Dose 1, CIN-103 Dose 2, and placebo, to evaluate the clinical response to multiple dose strengths of CIN-103 relative to placebo on abdominal pain and stool consistency along with safety and tolerability.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (53)

Digestive Health Specialists - DothanDothan, Alabama, United States
Clinical Research Associates, LLCHuntsville, Alabama, United States
Elite Clinical Studies LLCPhoenix, Arizona, United States
GI Alliance - Sun CitySun City, Arizona, United States
Applied Research Center of ArkansasLittle Rock, Arkansas, United States
Paragon Rx Clinical, Inc. - Garden GroveGarden Grove, California, United States
Gastro Care Institute- lancasterLancaster, California, United States
Medical Associates Research GroupSan Diego, California, United States
American Family Research GroupCape Coral, Florida, United States
USA and International Research Inc.Doral, Florida, United States
International Research Associates LLCMiami, Florida, United States
Innovation Medical Research CenterPalmetto Bay, Florida, United States

+ 41 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06153420